Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Pulmonx Corp stock

Learn how to easily invest in Pulmonx Corp stock.

Pulmonx Corp is a medical devices business based in the US. Pulmonx Corp shares (LUNG) are listed on the NASDAQ and all prices are listed in US Dollars. Pulmonx Corp employs 253 staff and has a trailing 12-month revenue of around $51.7 million.

How to buy shares in Pulmonx Corp

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LUNG – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Pulmonx Corp stock price (NASDAQ: LUNG)

Use our graph to track the performance of LUNG stocks over time.

Pulmonx Corp shares at a glance

Information last updated 2022-10-02.
Latest market close$17.35
52-week range$13.79 - $45.49
50-day moving average $19.01
200-day moving average $22.28
Wall St. target price$23.86
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.42

Buy Pulmonx Corp shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Pulmonx Corp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pulmonx Corp price performance over time

Historical closes compared with the close of $17.35 from 2022-10-03

1 week (2022-09-28) -0.97%
1 month (2022-09-02) -4.46%
3 months (2022-07-05) 1.94%
6 months (2022-04-05) -32.73%
1 year (2021-10-05) -54.81%
2 years (2020-10-05) -62.46%
3 years (2019-10-01) N/A
5 years (2017-10-01) N/A

Pulmonx Corp financials

Revenue TTM $51.7 million
Gross profit TTM $35.6 million
Return on assets TTM -14.14%
Return on equity TTM -28.08%
Profit margin -103.77%
Book value $4.62
Market capitalisation $635.8 million

TTM: trailing 12 months

Pulmonx Corp share dividends

We're not expecting Pulmonx Corp to pay a dividend over the next 12 months.

You may also wish to consider:

Pulmonx Corp overview

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. .

Frequently asked questions

What percentage of Pulmonx Corp is owned by insiders or institutions?
Currently 3.704% of Pulmonx Corp shares are held by insiders and 104.801% by institutions.
How many people work for Pulmonx Corp?
Latest data suggests 253 work at Pulmonx Corp.
When does the fiscal year end for Pulmonx Corp?
Pulmonx Corp's fiscal year ends in December.
Where is Pulmonx Corp based?
Pulmonx Corp's address is: 700 Chesapeake Drive, Redwood City, CA, United States, 94063
What is Pulmonx Corp's ISIN number?
Pulmonx Corp's international securities identification number is: US7458481014

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site